High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies

Journal:

Science Translational Medicine

Published:

2025-08-20

DOI:

10.1126/scitranslmed.adt9853

Affiliations:

6

Authors:

20

Go to article

Institutions	Authors	Share
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	12.000000 12.000000	0.60
NIH NIAID Vaccine Research Center (VRC), United States of America (USA)	3.000000	0.15
NIH NIAID Division of Intramural Research (DIR), United States of America (USA)	3.000000	0.15
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), United States of America (USA)	2.000000	0.10

Interested in Medical Microbiology?